Jefferies Starts Amarin Corporation (AMRN) at Buy

Article Stock Quotes (1) Comments (0)

Jefferies initiates coverage on Amarin Corporation (NASDAQ: AMRN) with a Buy rating and $12 price target.

The firm said, "We believe AMR101 offers robust efficacy for hyperlipidemia, lowering triglycerides (TG) without raising cholesterol like Lovaza. With a cleaner profile and potentially a broader label, we believe AMR101 could realize a multibillion-dollar opportunity."

For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.

Shares of Amarin Corporation closed at $8.84 yesterday, with a 52 week range of $0.93-$9.66.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Amarin (AMRN) NCE Delay Not all Negative - MKM Partners
• Amarin (AMRN) Vascepa NCE Not in Latest FDA Orange Book Update
• Wells Fargo Starts Quintiles (Q) at Outperform

Create E-mail Alert Related Categories

New Coverage

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?